BIOF on OTC
BLUE BIOFUELS, INC.
Price unavailable
Last updated Oct 16, 2026.
Overview
Compare with Quantum Genesis AI Corp., GREENWAY TECHNOLOGIES, INC. & SUBSIDIARIES or SUIC Worldwide Holdings Ltd., or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2019
Where the money goes
Where each dollar of revenue went, fiscal 2019
- Research and development44¢$797.9K
- Profit56¢$1.0M
Out of $60.0K in revenue.3
Financial statements
Every line of the income statement in the latest annual report, as filed.6
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| General and administrative | $1.4M | $1.7M |
| Research and development | $2.3M | $2.3M |
| Loss on disposal of assets | $1.4K | |
| Total operating expenses | $3.7M | $4.1M |
| Loss from operations: | -$3.7M | -$4.1M |
| Grants Income | -$865.0K | -$285.0K |
| Gain on extinguishment of debt | -$2.4M | |
| Interest expensed or (earned) - other | -$9 | $9.9K |
| Total other (income) expense | -$840.5K | -$2.6M |
| Income (Loss) before provisions for income taxes | -$2.9M | -$1.4M |
| Net Income (Loss): | -$2.9M | -$1.4M |
| Net income (loss) per share - basic | -$0.01 | -$0.01 |
| Net income (loss) per share - diluted | -$0.01 | -$0.01 |
| Basic | 312.2M shares | 303.9M shares |
| Diluted | 312.2M shares | 303.9M shares |
Every line of the balance sheet in the latest annual report, as filed.6
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and Cash Equivalents | $65.2K | $48.8K | |
| Prepaid Expenses | $11.6K | $32.5K | |
| TOTAL CURRENT ASSETS | $76.8K | $81.3K | |
| Property and Equipment, net of accumulated depreciation and amortization of $482,578 and $361,887 at December 31, 2025 and December 31, 2024, respectively | $555.1K | $539.6K | |
| Deposits | $80.3K | $30.3K | |
| Right of Use Assets, net of accumulated amortization | $365.4K | $440.3K | |
| Patents and Trademarks, net of accumulated amortization | $329.8K | $298.1K | |
| TOTAL OTHER ASSETS | $1.3M | $1.3M | |
| TOTAL ASSETS | $1.4M | $1.4M | |
| Right of Use Lease Liability - Current | $79.3K | $68.7K | |
| Interest Payable - Related Party | $176.5K | $185.7K | |
| TOTAL CURRENT LIABILITIES | $3.0M | $2.2M | |
| Right of Use Lease Liability, Long Term | $293.4K | $372.7K | |
| Legacy Notes Payable | $320.6K | $320.6K | |
| TOTAL LONG TERM LIABILITIES | $2.1M | $2.0M | |
| TOTAL LIABILITIES | $5.1M | $4.2M | |
| Common stock; $0.001 par value; 1,000,000,000 shares authorized; 317,872,112 issued and outstanding at December 31, 2025, and 307,960,508 issued and outstanding at December 31, 2024. | $317.9K | $308.0K | |
| Additional paid-in capital | $56.1M | $54.1M | |
| Accumulated deficit | -$60.1M | -$57.3M | |
| TOTAL STOCKHOLDERS DEFICIT | -$3.7M | -$2.8M | -$3.6M |
| TOTAL LIABILITIES AND STOCKHOLDERS DEFICIT | $1.4M | $1.4M | |
| Property and equipment, net of accumulated depreciation and amortization | $482.6K | $361.9K | |
| Preferred stock, par value | $0.00 | $0.00 | |
| Preferred stock, shares authorized | 10.0M shares | 10.0M shares | |
| Preferred stock, shares issued | 0 shares | 0 shares | |
| Preferred stock, shares outstanding | 0 shares | 0 shares | |
| Common stock, par value | $0.00 | $0.00 | |
| Common stock, shares authorized | 1.0B shares | 1.0B shares | |
| Common stock, shares issued | 317.9M shares | 308.0M shares | |
| Common stock, shares outstanding | 317.9M shares | 308.0M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.6
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net Income (Loss) | -$2.9M | -$1.4M |
| Depreciation and amortization | $145.9K | $118.8K |
| Stock based compensation | $1.0M | $1.7M |
| Extinguishment of debt | -$2.4M | |
| Issuance of warrants for interest expense | $24.5K | $12.4K |
| Loss on Disposal of assets | $1.4K | |
| Prepaid expenses | $20.9K | $3.3K |
| Accounts payable | -$66.1K | $200.6K |
| Accounts payable - related party | -$24.1K | |
| Deferred wages and directors fees - related party | $917.3K | $779.6K |
| Interest payable - related party | -$9.2K | $42.3K |
| Net cash used in operating activities | -$845.0K | -$1.0M |
| Purchase of property and equipment | -$68.9K | -$71.1K |
| Payment of deposits on property | -$50.0K | |
| Additions to patent and trademark costs | -$18.4K | -$44.7K |
| Net cash from (used in) investing activities | -$137.3K | -$115.8K |
| Proceeds from issuance of common stock | $745.0K | $197.0K |
| Proceeds from the issuance of convertible notes - RP | $185.0K | $680.0K |
| Proceeds from the issuance of convertible notes - Other | $250.0K | |
| Proceeds from exercise of warrants | $68.8K | |
| Net cash provided by financing activities | $998.8K | $1.1M |
| Net increase (decrease) in cash and cash equivalents | $16.4K | $7.8K |
| Recognition of operating lease liability and right-of-use asset | $452.1K | |
| Issuance of common stock for patent and trademark costs | $38.5K | |
| Issuance of common stock for property and equipment | $67.3K | |
| Issuance of common stock and warrants on the conversion of notes payable | $50.0K | $250.0K |
Former names
Recent filings
- Oct 13, 2026144
- Sep 8, 20264
- Sep 3, 2026144
- Sep 3, 20264
- Aug 10, 202610-Q
- Jun 26, 2026D/A
- Jun 9, 20268-K
- May 4, 202610-Q
- Mar 19, 202610-K
- Dec 5, 2025D
- Oct 23, 202510-Q
- Jul 31, 202510-Q
- Apr 30, 202510-Q
- Mar 19, 202510-K
- Jan 10, 20254
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7